Concomitant treatment for overactive bladder (other than estrogen replacement therapy started at least 2 months prior to ... to oral therapy with either tolterodine 2mg twice daily or placebo ...
Furthermore, the proportion of patients able to finish tasks before voiding increased by 5-fold after tolterodine therapy, compared with a 2-fold increase for those patients on placebo.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback